Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2020Kidney InternationalOpen Access

New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction

View Full Paper
Ask AI
Bookmark
Share

Authors

Hiddo J.L. Heerspink
Hiddo J.L. HeerspinkPreventive Cardiology
DKDonald E. KohanBrigham and Women's Hospital
Dick de Zeeuw
Dick de ZeeuwPreventive Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heerspink et al. (2020) studied this question.

synapsesocial.com/papers/6a053bbd0012b80f37a201cehttps://doi.org/10.1016/j.kint.2020.09.026
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease2007 · 62 citations
  2. 2Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus2016 · 1,379 citations
  3. 3Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist2014 · 31 citations
  4. 4Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy2019 · 6,243 citations
  5. 5One‐to‐many propensity score matching in cohort studies2012 · 534 citations